Activist investor Nelson Peltz's Trian Fund Management dramatically increased its investment in GE HealthCare during the second quarter of 2026. The firm's stake grew from just 4,044 shares to over 3.08 million, elevating the position's reported value from approximately $288,000 to nearly $197.5 million. This new holding now constitutes a significant 4.67% of Trian's reported portfolio.
This investment expands on Peltz's long-running involvement with GE before its breakup. Trian also maintained its large, steady position in GE Aerospace, indicating a bullish stance on the successor companies. As with all 13F filings, it is important to note this disclosure is delayed, reflecting the firm's holdings as of June 30, 2026, and may not represent its current position.